Single-dose Johnson & Johnson Vaccine 66% Effective Against Covid-19, Drops Against SA Variant
Johnson & Johnson has said that its single-dose vaccine is 66% effective in preventing Covid-19 in a large global trial against multiple variants, giving health officials another weapon to tackle